Medigene AG announced that its Supervisory Board has appointed Axel-Sven Malkomes as Chief Financial Officer and Chief Business Development Officer effective 1 April 2019. As a member of the Executive Management, Mr. Malkomes will be working at the Munich headquarters of Medigene and will assume responsibility for Finance, Business Development, Public Investor Relations, Legal Affairs, IT and Commercial Operations. Axel-Sven Malkomes has been active in the healthcare sector for more than 25 years.

Most recently, he has been Managing Director of the Life Sciences Practice for the British bank Barclays in Europe. Previously, he served as Global Head of Healthcare Chemicals Investment Banking at the French corporate and investment bank Societe Generale. Previously, he had leading operational and corporate roles at the German pharmaceutical company Merck KGaA, i.e. as CEO of a Merck KGaA group company and as Head of Strategic Planning as well as Mergers Acquisitions/Business Development, where he significantly participated in the initial set-up and build-out of the company's oncology business.